创美药业(02289)发布中期业绩 归母净利润2173.9万元 同比减少18.72%

Group 1 - The core point of the article is that Chuangmei Pharmaceutical (02289) reported a total revenue of 2.155 billion RMB for the six months ending June 30, 2025, representing a year-on-year decrease of 8.18% [1] - The net profit attributable to the parent company was 21.739 million RMB, which is a year-on-year decrease of 18.72% [1] - The basic earnings per share were reported at 0.2013 RMB [1]